As of March 23, 2026, the three largest insider holders of OLMA are Capital Life Sciences Investors, Llc Bain (TenPercentOwner, 4.30Mn shares), Biocapital Advisors Lp Paradigm (TenPercentOwner, 783.12K shares), Cyrus Harmon (Director, 727.77K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Life Sciences Investors, Llc Bain | 0 | 4,300,000 | 13 Jan, 2025 | |
| Biocapital Advisors Lp Paradigm | 0 | 783,118 | 05 Aug, 2024 | |
| Cyrus Harmon | 727,770 | 0 | 21 Jan, 2026 | |
| G. Walmsley Graham | 0 | 700,761 | 18 Dec, 2024 | |
| David C. Myles | Ch. Discov. Non Clin Dev Off | 542,761 | 144,846 | 14 Jan, 2026 |
| Andrew Rappaport | 0 | 385,965 | 06 Mar, 2024 | |
| Sean Bohen | President And Ceo | 237,650 | 0 | 29 Dec, 2025 |
| Shane William Charles Kovacs | Ch. Operating Financial Off. | 139,727 | 0 | 15 Jan, 2026 |
| Cyrus Harmon | 0 | 117,028 | 18 Sep, 2025 | |
| Sasha Lu Austin | Vp Of Finance And Controller | 16,188 | 0 | 17 Feb, 2026 |
| Naseem Zojwalla | Chief Medical Officer | 4,488 | 0 | 23 Dec, 2025 |
| Kinney Horn | Chief Business Officer | 2,458 | 0 | 14 Mar, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Mar, 2026 | Shawnte Mitchell | Common Stock | A | 15,000 | $4.37 | 15,000 | D | M |
| 03 Mar, 2026 | Shawnte Mitchell | Common Stock | D | 15,000 | $23.01 | 0 | D | S |
| 04 Mar, 2026 | Shawnte Mitchell | Common Stock | A | 25,000 | $4.37 | 25,000 | D | M |
| 04 Mar, 2026 | Shawnte Mitchell | Common Stock | D | 24,767 | $24.25 | 233 | D | S |
| 04 Mar, 2026 | Shawnte Mitchell | Comon Stock | D | 233 | $24.69 | 0 | D | S |
| 03 Mar, 2026 | Shawnte Mitchell | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 435,000 | D | M |
| 04 Mar, 2026 | Shawnte Mitchell | Stock Option (Right to Buy) | D | 25,000 | $0.00 | 410,000 | D | M |
| 02 Feb, 2026 | Sasha Lu Austin | Common Stock | A | 11,700 | $0.00 | 16,188 | D | A |
| 02 Feb, 2026 | Sasha Lu Austin | Stock Option (Right to Buy) | A | 29,250 | $0.00 | 29,250 | D | A |
| 02 Feb, 2026 | Shawnte Mitchell | Stock Option (Right to Buy) | A | 220,000 | $0.00 | 220,000 | D | A |
| 02 Feb, 2026 | Naseem Zojwalla | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 02 Feb, 2026 | David C. Myles | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 02 Feb, 2026 | Sean Bohen | Stock Option (Right to Buy) | A | 850,000 | $0.00 | 850,000 | D | A |
| 02 Feb, 2026 | Naseem Zojwalla | Performance Stock Options (Right to Buy) | A | 106,250 | $0.00 | 106,250 | D | A |
| 02 Feb, 2026 | Shawnte Mitchell | Performance Stock Options (Right to Buy) | A | 56,250 | $0.00 | 56,250 | D | A |
| 02 Feb, 2026 | David C. Myles | Performance Stock Options (Right to Buy) | A | 106,250 | $0.00 | 106,250 | D | A |
| 02 Feb, 2026 | Sean Bohen | Performance Stock Options (Right to Buy) | A | 275,000 | $0.00 | 275,000 | D | A |
| 20 Jan, 2026 | Cyrus Harmon | Common Stock | D | 10,000 | $26.88 | 727,770 | D | S |
| 14 Jan, 2026 | Cyrus Harmon | Common Stock | D | 3,489 | $29.12 | 737,770 | D | S |
| 13 Jan, 2026 | Shane William Charles Kovacs | Common Stock | D | 3,822 | $28.01 | 239,727 | D | S |